Nathalia Souza, a 37-year-old from New Jersey, started taking tirzepatide after three years of dieting and exercising resulted in just 30 pounds of weight loss
One large cohort reports almost 50% deceased patients [23, 25]
Ongoing Research KLOW remains an active area of investigation across regenerative biology, connective tissue physiology, immunology, gastrointestinal research, dermatology, vascular biology, and peptide pharmacology
Yes, particularly submucosal fibroids (those distorting the uterine cavity), which interfere with embryo implantation and increase miscarriage risk
What the FDA Has Said About BPC-157 and Compounding In September 2023, the FDA put BPC-157 in Category 2 of the 503A Interim Bulks Guidance, which stopped pharmacies from compounding it
2020;7:e697